Follow us

About us

Founded in 2015 by two scientists, Géraldine Le Duc (CEO of NH TherAguix) and Pr Olivier Tillement (Professor of Chemistry at University of Lyon), NH TherAguix is a French biotechnology company based in Grenoble. NH TherAguix has developed an innovative theranostic nanodrug called AGuIX® that allows to fight more efficiently against all forms of cancer. 
Thanks to a €13M fund raising in 2019 (BPI, Innobio, Omnes, Arbevel, Supernova), NH THerAguix was able to launch a promising portfolio of clinical trials.

Management

Géraldine Leduc

Géraldine Le Duc, PhD

Chief Executive Officer & Co-Founder

  • 30 years of expertise in drugs for radiotherapy and imaging of cancer (Guerbet, INSERM, BNL-USA, ESRF)
  • More than 100 scientific publications, 4 patents
  • Discovery of the radiosensitization effect of AGuIX®
  • PhD in Biomedical Physics
Olivier de Beaumont

Olivier de Beaumont, MD & MBA

Chief Medical Officer

  • Senior pharma/biotech business leader (Onxeo, Stallergenes, Sanofi)
  • More than 25 years of experience at Comex level, in charge of clinical development programs, regulatory affairs, medical affairs and drug safety surveillance.
  • Combination of business and drug development, with international experience in R&D, translational research, organizational and business development.
Olivier de Beaumont

Hervé Brailly, PhD

Chairman of the Board

  • Founder and CEO of Innate Pharma from 1999 to 2016, then President
  • Chairman and co-founder of Kalsiom, Systol Dynamics an co-founder of MI-MAbs
  • Expertise in all stages of research and clinical development from first in human to market
  • PhD, Ecole Mines de Paris
Frederic Griolet, PhD

Frederic Griolet, PhD

Chief Industrialization Officer (CMC)

  • Senior CMC expert (production/industrialization of pharmaceutical APIs)
  • >25 years of experience (Sanofi, Sanofi Aventis, Merck)
  • PhD, ICPI Lyon
caroline-cayre

Caroline Cayre

Head of Finance and Administration

  • 25+ years spent in Finance & Business administration, including 15 years in international business environment
  • Broad industry experience: Audit (PwC), Large international groups (HP), Fast growing SMEs/Start-ups (Aledia)
  • French Business School (1995) – Studies abroad (Bath-UK), Certified Coach (Teams & Organizations)

Board of directors

Géraldine Leduc

Géraldine Le Duc

CEO & Co-Founder

herve-brailly

Hervé Brailly

Chairman

philippe-boucheron

Philippe Boucheron

Life Sciences Investor
Bpifrance

thibaut-roulon

Thibaut Roulon

Life Sciences Investor
Bpifrance

herve-brailly

Nitza Thomasson

Life Sciences Investor
Omnes

marc-lebozec

Marc Lebozec

Life Sciences Investor
Arbevel

marc-lebozec

Célia Hart

Life Sciences Investor
Supernova

yannick-pletan

Yannick Pletan

Formely Country Medical Director
Roche

philippe-archinard

Philippe Archinard

Deputy CEO-Innovation & Scientific Partnerships
Institut Mérieux

Partners

BPI France
Arbevel
Omnes
Supernova
Pulsayis
Université Claude Bernard Lyon 1
Région Auvergne Rhône-Alpes